Compile Data Set for Download or QSAR
Report error Found 76 Enz. Inhib. hit(s) with all data for entry = 1123
TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310701(US10150763, Example A)
Affinity DataIC50: 1.76nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310701(US10150763, Example A)
Affinity DataIC50: 226nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310715(US10150763, Example O | N-Hydroxy-7-(pyridin-2-yl(...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310738(US10150763, Example LL)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310716(US10150763, Example P | N-Hydroxy-8-(pyridin-2-yl(...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310717(US10150763, Example Q | 7-((5-Fluoropyridin-2-yl)(...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310718(US10150763, Example R | 8-((5-Fluoropyridin-2-yl)(...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310719(US10150763, Example S | 7-((5-Fluoropyridin-2-yl)(...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310720(US10150763, Example T | 8-((5-Fluoropyridin-2-yl)(...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310721(US10150763, Example U | 7-((5-Fluoropyridin-2-yl)(...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310722(US10150763, Example V | 8-((5-Fluoropyridin-2-yl)(...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310723(US10150763, Example W | 7-(Benzo[d]oxazol-2-yl(5-f...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310724(US10150763, Example X | 8-(Benzo[d]oxazol-2-yl(5-f...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310725(US10150763, Example Y | 7-((4-(4-Fluorophenyl)pyri...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310725(US10150763, Example Y | 7-((4-(4-Fluorophenyl)pyri...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310726(US10150763, Example Z | 8-((4-(4-Fluorophenyl)pyri...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310727(US10150763, Example AA | 7-((5-Fluoropyridin-2-yl)...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310728(US10150763, Example BB | 8-((5-Fluoropyridin-2-yl)...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310729(US10150763, Example CC | 7-((5-Fluoropyridin-2-yl)...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310730(US10150763, Example DD | 8-((5-Fluoropyridin-2-yl)...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310731(US10150763, Example EE | 7-((4-(4-Fluorophenyl)pyr...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310732(US10150763, Example FF | 8-((4-(4-Fluorophenyl)-py...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310733(US10150763, Example GG | 7-((5-Fluoropyridin-2-yl)...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310734(US10150763, Example HH | 8-((5-Fluoropyridin-2-yl)...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310735(US10150763, Example II | 7-(Benzo[d]thiazol-2-yl(p...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310736(US10150763, Example JJ | 8-(Benzo[d]thiazol-2-yl(p...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310737(US10150763, Example KK | N-Hydroxy-7-(pyridin-2-yl...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310705(US10150763, Example E | N-Hydroxy-7-((1-methyl-1H-...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310709(US10150763, Example I | N-Hydroxy-7-((5-methyl-1,3...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310708(US10150763, Example H | N-Hydroxy-8-(pyridin-2-yl(...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310707(US10150763, Example G | N-Hydroxy-7-(pyridin-2-yl(...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310707(US10150763, Example G | N-Hydroxy-7-(pyridin-2-yl(...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310710(US10150763, Example J | N-Hydroxy-8-((5-methyl-1,3...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310711(US10150763, Example K | 7-(Benzo[d]oxazol-2-yl(pyr...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310706(US10150763, Example F | N-Hydroxy-8-((1-methyl-1H-...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310711(US10150763, Example K | 7-(Benzo[d]oxazol-2-yl(pyr...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310705(US10150763, Example E | N-Hydroxy-7-((1-methyl-1H-...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310712(US10150763, Example L | 8-(Benzo[d]oxazol-2-yl(pyr...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310704(US10150763, Example D | N-Hydroxy-8-((3-methyl-1,2...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310703(US10150763, Example C | N-Hydroxy-7-((3-methyl-1,2...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310703(US10150763, Example C | N-Hydroxy-7-((3-methyl-1,2...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310713(US10150763, Example M | N-Hydroxy-7-((1-methyl-1H-...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310702(US10150763, Example B | N-Hydroxy-7-[(3-methyl-1,2...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310702(US10150763, Example B | N-Hydroxy-7-[(3-methyl-1,2...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 6(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310714(US10150763, Example N | N-Hydroxy-8-((1-methyl-1H-...)
Affinity DataIC50: 500nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310715(US10150763, Example O | N-Hydroxy-7-(pyridin-2-yl(...)
Affinity DataIC50: 750nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310733(US10150763, Example GG | 7-((5-Fluoropyridin-2-yl)...)
Affinity DataIC50: 750nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310729(US10150763, Example CC | 7-((5-Fluoropyridin-2-yl)...)
Affinity DataIC50: 750nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310719(US10150763, Example S | 7-((5-Fluoropyridin-2-yl)(...)
Affinity DataIC50: 750nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Karus Therapeutics

US Patent
LigandPNGBDBM310709(US10150763, Example I | N-Hydroxy-7-((5-methyl-1,3...)
Affinity DataIC50: 750nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 76 total ) | Next | Last >>
Jump to: